| Titel | Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692) |
|---|---|
| Gepubliceerd in | Brain: a journal of neurology. ISSN 0006-8950. |
| Auteur | Forey, F.; Tanghe, H.L.J. (Hervé); Niermeijer, M.F. (Martinus); Duijn, van C.M. (Cock); Swieten, van J.C.; Harskamp, van F. (Frans); Koning, de I. (Inge); Cruts, M. (Marc); Jonghe, de C. (Chris); Kumar-Singh, S. (Samir); Tibben, A. (Arend); Broeckhoven, van C. (Christine); Hofman, A. (Albert) |
| Datum | 2000-01-01 |
| Trefwoord(en) | Male, Adult, Female, Humans, Middle aged, Research Support, Non-U.S. Gov't, Pedigree, Genetic Predisposition to Disease, Age of Onset, Family Health, Neuropsychological Tests, *Heterozygote, *Mutation, Missense, Alzheimer Disease/*genetics/pathology, Amyloid beta-Protein Precursor/*genetics, Amyloidosis/*genetics/pathology |
| Taal | Engels |
| Type | artikel |
| Samenvatting | Several mutations in the amyloid precursor protein (APP) gene may lead to either Alzheimer's disease or cerebral haemorrhage due to congophilic amyloid angiopathy (CAA). A single family is known in which both types of pathology are expressed because of a missense mutation at codon 692 of the APP gene (APP692). Here we describe the clinical and pathological expression of APP692 in eight patients with the mutation. Furthermore, 21 first-degree relatives with an a priori risk of 50% of being a carrier were tested for the APP692 mutation and studied for presymptomatic signs by neurological examination, neuropsychological testing and brain MRI. Patients with APP692 presented with haemorrhage, dementia or both. The dementia in patients with the APP692 mutation was compatible with Alzheimer's disease both clinically and neuropathologically. Of the 21 healthy relatives at 50% risk, five carried the APP692 mutation. The presymptomatic carriers showed a subtle, non-significant impairment of cognitive function compared with relatives without APP692. A significant increase in the number of periventricular and subcortical white matter lesions at young age was seen in presymptomatic carriers (mean age 26.4 years). The findings of this study suggest that a single (genetic) mechanism may underlie the pathology of Alzheimer's disease and CAA. These diseases are manifested subclinically by white matter pathology. Further insight into the relationship between CAA and Alzheimer's disease may provide clues about the aetiology of Alzheimer's disease. |
| Publicatie | http://hdl.handle.net/1765/9469 |
| Persistent Identifier | urn:NBN:nl:ui:15-1765/9469 |
| Metadata | XML |
| Repository | Erasmus Universiteit Rotterdam |
Omhoog
Ga terug naar de inhoud
Ga terug naar de site navigatie